Healthcare -
Biotechnology - NASDAQ - US
$ 246.27
-1.16 %
$ 31.8 B
Market Cap
-94.0
P/E
ALNY - OTHER CURRENT ASSETS
Other Current Assets ALNY - Alnylam Pharmaceuticals, Inc.
126 M
LAST VALUE
19.79%
2 YEAR CAGR
11.39%
5 YEAR CAGR
32.08%
10 YEAR CAGR